Curt LaBelle, MD

Dr. LaBelle has been actively involved in the healthcare industry for 16 years, both operationally and as an investor. He has a long history in pharmaceuticals and ophthalmology, serving as a director at Sirion Therapeutics (developer of Durezol and Zirgan), among others. As an investment manager for the Global Health Investment Fund, Dr. LaBelle evaluates late-stage products for conditions disproportionately affecting low and middle income countries. As a director at Eyenovia, Dr. LaBelle supports business development and financing efforts. Dr. LaBelle earned MD and MBA degrees from Columbia University.